Dysregulation of certain CRISP proteins in malignant cells hints at their potential roles in cancer progression; for instance, CRISP3 is significantly upregulated in prostate cancer, where it serves as a diagnostic and prognostic marker, and cholesterol has a likely role in the progression to advanced disease (16, 17). Here, CRISP3 is linked to cancer.